Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
A new study developed a mineralized DNA hydrogel that combines immune regulation with sustained bone regeneration. Using ...
The South San Francisco biotech plans to begin its first human trial of a liver cell-reprogramming therapy next year ...
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
In a recent study posted to the bioRxiv* preprint server, researchers performed age-reversing experiments, in vivo and in vitro, in progeroid mice using gene therapy. Study: Gene Therapy Mediated ...
Morning Overview on MSN
A Johns Hopkins-Texas A&M mouse study found 7% of inherited DNA methylation patterns ignore Mendel’s rules across three generations
Researchers at Johns Hopkins University and Texas A&M University have documented at least 522 autosomal sites where DNA ...
Mesenchymal drift may help explain how cells lose stable identity and acquire pro-fibrotic, inflammatory mesenchymal traits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results